PPARGC1A and metabolic dysfunction-associated steatotic liver disease: The liver mtDNA/nDNA ratio was significantly higher in control livers compared with NAFLD livers. mtDNA/nDNA ratio was inversely correlated with PPARGC1A promoter methylation.